Cargando…

No histology for diminutive duodenal neuroendocrine tumors: Is it safe?

For the management of diminutive duodenal neuroendocrine tumors (d-NETs), Harshit et al. have proposed – in the work accompanying this editorial – an interesting approach, the endoscopic banding without resection (BWR) technique. Given the risks associated with classic endoscopic resections and surg...

Descripción completa

Detalles Bibliográficos
Autor principal: Walter, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: © Georg Thieme Verlag KG 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368482/
https://www.ncbi.nlm.nih.gov/pubmed/30747160
http://dx.doi.org/10.1055/a-0650-4478
_version_ 1783393992622211072
author Walter, Thomas
author_facet Walter, Thomas
author_sort Walter, Thomas
collection PubMed
description For the management of diminutive duodenal neuroendocrine tumors (d-NETs), Harshit et al. have proposed – in the work accompanying this editorial – an interesting approach, the endoscopic banding without resection (BWR) technique. Given the risks associated with classic endoscopic resections and surgical procedures, and the likely favorable natural history of diminutive d-NETs, BWR may be an option for these selected patients with a very low risk of LN + and recurrence. However, a close follow-up (endoscopic, EUS and thoraco-abdominal CT scan) is then required to guarantee the safety of this policy.
format Online
Article
Text
id pubmed-6368482
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher © Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-63684822019-02-11 No histology for diminutive duodenal neuroendocrine tumors: Is it safe? Walter, Thomas Endosc Int Open For the management of diminutive duodenal neuroendocrine tumors (d-NETs), Harshit et al. have proposed – in the work accompanying this editorial – an interesting approach, the endoscopic banding without resection (BWR) technique. Given the risks associated with classic endoscopic resections and surgical procedures, and the likely favorable natural history of diminutive d-NETs, BWR may be an option for these selected patients with a very low risk of LN + and recurrence. However, a close follow-up (endoscopic, EUS and thoraco-abdominal CT scan) is then required to guarantee the safety of this policy. © Georg Thieme Verlag KG 2019-02 2019-02-08 /pmc/articles/PMC6368482/ /pubmed/30747160 http://dx.doi.org/10.1055/a-0650-4478 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Walter, Thomas
No histology for diminutive duodenal neuroendocrine tumors: Is it safe?
title No histology for diminutive duodenal neuroendocrine tumors: Is it safe?
title_full No histology for diminutive duodenal neuroendocrine tumors: Is it safe?
title_fullStr No histology for diminutive duodenal neuroendocrine tumors: Is it safe?
title_full_unstemmed No histology for diminutive duodenal neuroendocrine tumors: Is it safe?
title_short No histology for diminutive duodenal neuroendocrine tumors: Is it safe?
title_sort no histology for diminutive duodenal neuroendocrine tumors: is it safe?
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368482/
https://www.ncbi.nlm.nih.gov/pubmed/30747160
http://dx.doi.org/10.1055/a-0650-4478
work_keys_str_mv AT walterthomas nohistologyfordiminutiveduodenalneuroendocrinetumorsisitsafe